Viewing nowCombinationJanustine Duo Tablets 10/100 Milligrams
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.

MFDS item code 202300384 · Approved 2023.01.30 · Insurance code 665003240
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to assist patients with type 2 diabetes in controlling their blood sugar levels by using sitagliptin and dapagliflozin together. It helps to effectively improve blood sugar levels in conjunction with dietary therapy and exercise therapy. Thus, it is a suitable treatment method for those who have difficulty managing their blood sugar.
This medicine may be administered as 1 tablet once daily, with or without food, to patients receiving sitagliptin 100 mg and dapagliflozin 10 mg. Tablets should be swallowed whole. Patients with renal impairment The efficacy and safety of this medicine vary according to renal function. It is recommended that renal function be assessed before treatment with this medicine and periodically thereafter. - No dose adjustment is necessary if the estimated glomerular filtration rate (eGFR) is 45 mL/min/1.73m2 or higher. - Do not administer this medicine if the estimated glomerular filtration rate (eGFR) is less than 45 mL/min/1.73 m2. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.
This medication contains sitagliptin and dapagliflozin. First, sitagliptin can rarely cause severe allergic reactions; if symptoms such as skin rash or difficulty breathing occur, discontinue use immediately and consult a physician. Additionally, there is a risk of acute pancreatitis, so caution should be exercised if there is severe abdominal pain or vomiting. Next, dapagliflozin may lead to decreased body fluid, lowering blood pressure or worsening kidney function, so if symptoms of dehydration or dizziness occur, promptly inform healthcare professionals. This medication may also increase the risk of genital infections, so if itching or discomfort occurs, treatment should be sought. This medication is not suitable for patients with type 1 diabetes or patients undergoing dialysis, and dose adjustments may be needed for patients with impaired kidney function. Elderly patients should also monitor kidney function regularly and take this medication with caution. Pregnant or breastfeeding women are advised not to use this medication, as it may pass into breast milk and potentially affect the baby. Additionally, when used in conjunction with insulin or sulfonylurea medications, there may be an increased risk of hypoglycemia, so blood sugar levels should be checked frequently, and dosage adjustments may be necessary. In the case of overdose, seek medical attention immediately for appropriate treatment, as some of the medication may be removed through dialysis, but generally symptomatic treatment is recommended. Finally, the safety and efficacy of this medication have not been established in children, so it should not be used in individuals under 18 years of age. Care should be taken while driving or operating machinery during treatment, particularly when hypoglycemic symptoms are present, as the risk of accidents may increase. Considering all of the above, take this medication exactly as directed by your physician and consult a professional immediately if any abnormal symptoms occur.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius.
Yellow to orange, double-sided convex film-coated tablets
28 tablets/box [(7 tablets/Alu-Alu x 4)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.